John Stuelpnagel, Angel Investor

John Stuelpnagel is an angel investor focused on genomics, biotechnology, and life sciences companies. His investments include Arima Genomics, a genomic analysis company, and Volta Labs, a laboratory automation and sequencing technology startup. His investment activity has included growth-stage financings in the biotechnology sector. John participated in Arima Genomics’ Series C round, where the company raised a total of $22M, and Volta Labs’ Series A financing totaling $20M. John has served as Chairman of 10x Genomics for nearly thirteen years following the company’s public listing. He has also been Chairman of Manus for over a year and a Board Member at Encoded Therapeutics for more than nine years.